Quantitative ELISA-Like Immunohistochemistry of Fibroblast Growth Factor 23 in Diagnosis of Tumor-Induced Osteomalacia and Clinical Characteristics of the Disease

<div>FGF23 levels measured by quantitative ELISA-like immunohistochemistry using paraffin-embedded tissues of 14 TIO cases and 26 non-TIO cases.</div>

Disease Markers

fig3

Figure 3

Figure 3: Quantitative ELISA-Like Immunohistochemistry of Fibroblast Growth Factor 23 in Diagnosis of Tumor-Induced Osteomalacia and Clinical Characteristics of the Disease 

Figure 3 | Quantitative ELISA-Like Immunohistochemistry of Fibroblast Growth Factor 23 in Diagnosis of Tumor-Induced Osteomalacia and Clinical Characteristics of the Disease 